| 注册
首页|期刊导航|内科理论与实践|黄药子治疗Graves病有效性和安全性的研究进展

黄药子治疗Graves病有效性和安全性的研究进展

崔依帆 张瑞祥 韦晓 刘超

内科理论与实践2024,Vol.19Issue(4):273-277,5.
内科理论与实践2024,Vol.19Issue(4):273-277,5.DOI:10.16138/j.1673-6087.2024.04.11

黄药子治疗Graves病有效性和安全性的研究进展

Study on efficacy and safety of Dioscorea bublifera L.in treatment of Graves disease

崔依帆 1张瑞祥 1韦晓 1刘超1

作者信息

  • 1. 南京中医药大学附属中西医结合医院内分泌科 江苏省中医药研究院国家中医药管理局瘿病证治重点研究室,江苏 南京 210028
  • 折叠

摘要

Abstract

Hyperthyroidism is most common in Graves disease(GD),and traditional antithyroid medicine are often difficult to achieve satisfactory efficacy,and high recurrence rate and long course of treatment are the most prominent problems.Huangyaozi(Dioscorea bublifera L.),a traditional Chinese medicine,has the effect of"Xiao Ying"and has been widely used in the treatment of GD in recent years,but long-term use may cause liver and kidney damage.Therefore,more research on the efficacy and safety of Huangyaozi need to be done in the treatment of GD.

关键词

黄药子/Graves病/有效性/安全性/薯蓣皂苷元/肝毒性

Key words

Dioscorea bublifera L./Graves disease/Efficacy/Safety/Diosgenin/Hepatotoxicity

分类

医药卫生

引用本文复制引用

崔依帆,张瑞祥,韦晓,刘超..黄药子治疗Graves病有效性和安全性的研究进展[J].内科理论与实践,2024,19(4):273-277,5.

内科理论与实践

OACSTPCD

1673-6087

访问量0
|
下载量0
段落导航相关论文